JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
IDXG - Interpace Biosciences, Inc.
USD | OTC Markets | Healthcare
Summary
Summary IDXG Stock
Financials
Financials IDXG Stock
Loading...
Loading...
Income Statement
Income Statement IDXG Stock
Balance Sheet
Balance Sheet IDXG Stock
Cash Flow Statement
Cash Flow Statement IDXG Stock
Loading...
Loading...
IDXG Financials - Interpace Biosciences Income & Cash Flow | Ledgeburg
Home
Stocks
Interpace Biosciences, Inc. (IDXG)
Financials
Financials of IDXG
Loading...
Loading...
Loading...
Loading...
Revenue
$38.728M
Operating Income
$4.084M
Net Income
$24.575M
Share Count (Basic)
4.424M
Operating Cash Flow
$5.831M
Free Cash Flow
$5.475M
Cash And Short-Term Equivalents
$2.505M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
50M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
2M
4M
6M
8M
10M
12M
Q1 FY25
Q2 FY25
Annual
Quarterly
Net Income $USD
-20M
-10M
0
10M
20M
Annual
Quarterly
Margins
Gross
Operating
Net
-400%
-300%
-200%
-100%
0%
100%
FY2025
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
50%
100%
150%
200%
250%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26